Literature DB >> 8601708

Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M.

Z J Gu1, J Wijdenes, X G Zhang, M M Hallet, C Clement, B Klein.   

Abstract

Five cytokines activate the gp130 IL-6 transducer: ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor and oncostatin M. Human plasmacytoma cell lines, completely dependent on the addition of one of these five cytokines for their growth, were used to obtain anti-gp130 monoclonal antibodies specifically inhibiting one of these five cytokines without affecting the biological activity of the others. These antibodies should improve our understanding of the interaction of gp130 transducer using cytokines with gp130 transducer and facilitate the design of new cytokine inhibitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601708     DOI: 10.1016/0022-1759(95)00232-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  The length of the interleukin-11 receptor stalk determines its capacity for classic signaling.

Authors:  Juliane Lokau; Christoph Garbers
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

2.  Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling.

Authors:  Jan Sommer; Timo Effenberger; Elena Volpi; Georg H Waetzig; Marten Bernhardt; Jan Suthaus; Christoph Garbers; Stefan Rose-John; Doreen M Floss; Jürgen Scheller
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

Review 3.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

4.  Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.

Authors:  Karène Mahtouk; Jérôme Moreaux; Dirk Hose; Thierry Rème; Tobias Meissner; Michel Jourdan; Jean François Rossi; Steven T Pals; Hartmut Goldschmidt; Bernard Klein
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

5.  An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer.

Authors:  Christoph Garbers; Björn Spudy; Samadhi Aparicio-Siegmund; Georg H Waetzig; Jan Sommer; Christoph Hölscher; Stefan Rose-John; Joachim Grötzinger; Inken Lorenzen; Jürgen Scheller
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

6.  Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.

Authors:  P Ray; W Tang; P Wang; R Homer; C Kuhn; R A Flavell; J A Elias
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

7.  Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells.

Authors:  Madelene Lindkvist; Mulugeta M Zegeye; Magnus Grenegård; Liza U Ljungberg
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

Review 8.  Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy.

Authors:  Anissa A Widjaja; Sonia P Chothani; Stuart A Cook
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.